
Obesity-related asthma often shows poor response to standard treatments, necessitating alternative therapeutic approaches. Recent research emphasizes non-type 2 inflammatory pathways, metabolic syndrome associations, and small airway impairment in obesity-related asthma pathophysiology. Promising treatments under investigation include biologics, weight reduction interventions, and novel anti-obesity drugs. While weight loss remains the primary treatment, emerging pharmacological interventions targeting metabolic processes offer hope for improved management. Understanding obesity-related asthma's complexities is crucial for developing effective therapies and addressing this prevalent asthma phenotype.
Like
Save
Share